Last Updated: Monday, March 10, 2014, 16:01
UK-based GlaxoSmithKline Plc (GSK) Monday said it increased its stake in its Indian arm to 75 percent following the successful completion of a Rs 6,400 crore open offer.
Last Updated: Monday, March 10, 2014, 14:46
GlaxoSmithKline said on Monday it had paid 64 billion rupees to increase its stake in its Indian pharmaceuticals unit to 75 percent, as it banks on rising demand for medicines in emerging markets.
Last Updated: Thursday, February 20, 2014, 12:58
The government Thursday cleared Rs 6,400 crore FDI proposal of global healthcare company GlaxoSmithKline to acquire additional 24.33 percent stake in its India arm.
Last Updated: Monday, January 13, 2014, 15:16
GlaxoSmithKline Pharmaceuticals is already majority owned and controlled by the GSK Group.
Last Updated: Sunday, January 12, 2014, 14:59
The acquisition would result in foreign exchange inflows to the tune of Rs 6,400 crore, they added.
Last Updated: Sunday, January 05, 2014, 13:24
UK-based drug major GlaxoSmithKline is knocking at the FIPB's doors to raise stake in its India arm by acquiring an additional 24.33 percent for around Rs 6,400 crore.
Last Updated: Wednesday, December 25, 2013, 12:16
Unilever, GlaxoSmithKline and PepsiCo made big bang announcements during the year as they decided to enhance their play in the "strategic and emerging" Indian market.
Last Updated: Monday, December 16, 2013, 18:38
At the NSE, the stock shot-up by 18.90 percent to close the trade at Rs 2,925.
Last Updated: Monday, December 16, 2013, 12:33
Shares of GlaxoSmithkline Pharmaceuticals today skyrocketed by 20 percent after UK-based GlaxoSmithKline Plc announced a voluntary open offer to increase stake in its Indian subsidiary.
Last Updated: Monday, December 16, 2013, 09:30
GlaxoSmithKline Plc (GSK) is looking at hiking stake in GlaxoSmithKline Pharmaceuticals to up to 75 percent from 50.67 percent, in line with FMCG giant Unilever increasing stake in its Indian arm HUL earlier this year.
Last Updated: Monday, November 11, 2013, 13:40
Drug firm GlaxoSmithKline Pharmaceuticals (GSK) on Monday reported 33.73 percent decline in standalone net profit at Rs 100.95 crore for the third quarter ended September 30, 2013.
Last Updated: Wednesday, November 06, 2013, 16:01
GlaxoSmithKline (GSK) Consumer Healthcare Ltd reported 14.29 per cent increase in standalone net profit at Rs 146.93 crore for the third quarter ended September 30, aided by higher sales.
more videos >>